Considering the important role of inflammatory conditions and IL-1β in the occurrence and development of lung cancer, we hope that the inhibition of IL-1β induced by these nanoparticles will open new avenues for cancer treatment by targeting lung tumor inflammation. This evidence concerns the gene IL1B and lung cancer.